🇺🇸 FDA
Patent

US 9631192

Auto-recognizing therapeutic RNA/DNA chimeric nanoparticles (NP)

granted A61PA61P31/00A61P31/04

Quick answer

US patent 9631192 (Auto-recognizing therapeutic RNA/DNA chimeric nanoparticles (NP)) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P31/00, A61P31/04, A61P31/10, A61P31/12